Publication
Tumor Marker Heterogeneity in Ovarian Cancer: Clinical Implications of Pretreatment Monitoring of Serum Biomarkers for Recurrence Prediction.
Ahmad Alwazzan, Ahmad Badeghiesh, Majid Almansouri, Dahlia Mirdad, Razan Amjad, Zayd Jastaniah, Huda Altoukhi, Rayyan Hasanain, Abdulkareem Fayoumi, Hatim Almarzouki
- Source
- PubMed
- Retrieved
- Oct 1, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20261001-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
BACKGROUND: Ovarian cancer remains a highly lethal gynecological malignancy with heterogeneous clinical outcomes. Reliable pretreatment biomarkers are needed to improve prognostic stratification. This study aimed to evaluate variations in pretreatment serum cancer antigen 125 (CA-125),…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Ovarian Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available